PRPH · ProPhase Labs, Inc.
Substantial doubt about the company's ability to continue as a going concern.
“These conditions raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date that the financial statements are issued. Management’s plans do not alleviate this substantial doubt.”View the 10-Q filed Jun 30, 2026
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Repurchase Programs
| Program Announced | Authorized | Remaining | As of | Runs Through | Source |
|---|---|---|---|---|---|
| — | $15,000,000 | — | — | — | 8-K , filed 2025-08-19 |
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| 2021-12-28 | — | $100,000,000 | — | — | 10-Q , filed 2025-08-13 |
Cash spent on buybacks by quarter
Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2024-12-31 | $0 | 10-K, filed 2025-04-01 |
| 2023-12-31 | $588,000 | 10-K, filed 2025-04-01 |
| 2022-12-31 | $2,152,000 | 10-K, filed 2024-03-29 |
| 2021-12-31 | $917,000 | 10-K, filed 2023-03-29 |
| 2017-12-31 | $16,283,000 | 10-K, filed 2019-03-26 |